Stock Information
Beam Therapeutics Inc (BEAM)
Ticker Symbol: BEAM
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $3,233.94 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -0.6417
Revenue (TTM): $1.59 M
Dividend Yield: N/A%
ROE: -5.89%
Latest News
-
Bernstein Maintains Outperform on Beam Therapeutics, Lowers Price Target to $39
Wed, May 13, 2026 2:34 PM
-
Beam Therapeutics: Base Editing Is Moving From Platform Story To Regulatory Asset Story
Wed, May 13, 2026 9:46 AM
-
Beam Therapeutics to Present at 2026 RBC Capital Markets Global Healthcare Conference
Wed, May 13, 2026 7:00 AM
-
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q1 2026 Update
Tue, May 12, 2026 11:54 PM
-
Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel’s Ability to Restore Red Blood Cell Health and Function in Sickle Cell Disease at EHA2026
Tue, May 12, 2026 9:30 AM
Key Financials
Financial data not available
